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There has been a dramatic increase in the body of evidence demonstrating the benefits that come from health
research. In 2014, the funding bodies for higher education in the UK conducted an assessment of research using an
approach termed the Research Excellence Framework (REF). As one element of the REF, universities and medical
schools in the UK submitted 1,621 case studies claiming to show the impact of their health and other life sciences
research conducted over the last 20 years. The recently published results show many case studies were judged
positively as providing examples of the wide range and extensive nature of the benefits from such research,
including the development of new treatments and screening programmes that resulted in considerable reductions
in mortality and morbidity.
Analysis of specific case studies yet again illustrates the international dimension of progress in health research;
however, as has also long been argued, not all populations fully share the benefits. In recognition of this, in May
2013 the World Health Assembly requested the World Health Organization (WHO) to establish a Global Observatory
on Health Research and Development (R&D) as part of a strategic work-plan to promote innovation, build capacity,
improve access, and mobilise resources to address diseases that disproportionately affect the world’s poorest countries.
As editors of Health Research Policy and Systems (HARPS), we are delighted that our journal has been invited to help
inform the establishment of the WHO Global Observatory through a Call for Papers covering a range of topics relevant
to the Observatory, including topics on which HARPS has published articles over the last few months, such as
approaches to assessing research results, measuring expenditure data with a focus on R&D, and landscape analyses of
platforms for implementing R&D. Topics related to research capacity building may also be considered. The task of
establishing a Global Observatory on Health R&D to achieve the specified objectives will not be easy; nevertheless, this
Call for Papers is well timed – it comes just at the point where the evidence of the benefits from health research has
been considerably strengthened.
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The start of 2015 sees a dramatic increase in the body of
evidence demonstrating the benefits arising from health
research. Throughout 2014, the higher education fund-
ing bodies in the UK conducted an assessment of re-
search, termed the Research Excellence Framework
(REF), in which, for the first time, account was taken of
the impact on society of the research undertaken. As
part of this, UK universities and medical schools pro-
duced 1,621 case studies that aimed to show the bene-
fits, such as improved healthcare, arising from examples
of their health and other life sciences research con-
ducted over the last 20 years. Panels of experts, includ-
ing leading academics from many countries, published
their assessments of these case studies in December
2014 [1], with the full case studies and an analysis of the
results being made public in January 2015 [2,3].
As we recently anticipated [4], the expert panels con-
cluded that the case studies did indeed overwhelmingly
illustrate the wide range and extensive nature of the
benefits from health research. Main Panel A covered the
range of life sciences and its overview report states:
“MPA [Main Panel A] believes that the collection of im-
pact case studies provide a unique and powerful illustra-
tion of the outstanding contribution that research in the
fields covered by this panel is making to health, well-
being, wealth creation and society within and beyond the
UK” [3], p. 1. The section of the report covering public
health and health services research also notes that: “Out-
standing examples included cases focused on national
screening programmes for the selection and early diagno-
sis of conditions” [3], p. 30. In their section of the report,
the international experts say of the REF2014: “It is the
boldest, largest, and most comprehensive exercise of its
kind of any country’s assessment of its science” [3], p. 20.
The REF2014 is therefore attracting wide international
attention. Indeed, some of the methods used are already
informing studies in other countries, including, for ex-
ample, an innovative assessment recently published in
Health Research Policy and Systems (HARPS) identifying
the beneficial effects made on healthcare policies and
practice in Australia by intervention studies funded by
the National Health and Medical Research Council [5].
The REF also illustrates that, even when focusing on
the research from one country, there are examples of
studies in which there has been international collabor-
ation and which have built on research conducted else-
where. For example, one REF case study on screening
describes how a major UK randomised controlled trial
of screening for abdominal aortic aneurysms (AAA) in-
volving 67,800 men [6,7] was the most significant trial
globally. The trial provided the main evidence for the
policy to introduce national screening programmes for
AAA for men reaching 65 throughout the UK [2]. Theimportance of this trial lay partly in its size, given that it
accounted for over 50% of the men included in the
meta-analyses performed in the 2007 Cochrane review
[8] and the 2009 practice guideline from the US Society
for Vascular Surgery [9]. Nevertheless, two of the three
smaller studies that were also included in these two
meta-analyses came from outside the UK, specifically
from Denmark [10] and Australia [11].
Moreover, a recent paper published in HARPS also in-
cluded descriptions of how the research contributing to
new interventions often comes from more than one
country. These accounts are included in a separate set of
seven extensive case studies constructed to illustrate in-
novative ways to measure the time that can elapse be-
tween research being conducted and its translation into
improved health [12]. While being a separate set of case
studies, one of them does, nevertheless, explore the
international timelines involved in research on screening
for AAA, and, in addition to highlighting the key role of
the UK research, it also highlights that the pioneering
first screening study using ultrasound had been con-
ducted in 1983 on 73 patients in a US Army medical
base [13].
These case studies therefore further reinforce the well-
established argument that health research progress often
involves contributions from various countries. However,
as has long been argued, not all populations fully share
the benefits. In recognition of this, in May 2013, the
World Health Assembly requested the World Health
Organization (WHO), in its resolution 66.22, to establish
a Global Observatory on Health Research and Develop-
ment as part of a strategic work-plan to promote
innovation, build capacity, improve access, and mobilise
resources to address diseases that disproportionately
affect the world’s poorest countries [14].
As editors of HARPS, we are delighted that our journal
has been invited to help inform the establishment of the
WHO Global Observatory by publishing a series of pa-
pers whose publication costs will be funded by the
WHO. In support of this WHO initiative, Taghreed
Adam, John-Arne Røttingen, and Marie-Paule Kieny re-
cently published a Call for Papers for this series [15],
which can be accessed through the HARPS webpage.
The aim of the series is “to contribute state-of-the-art
knowledge and innovative approaches to analyse, inter-
pret, and report on health R&D information… [and] to
serve as a key resource to inform the future WHO-
convened coordination mechanism, which will be utilized
to generate evidence-informed priorities for new R&D in-
vestments to be financed through a proposed new global
financing and coordination mechanism for health R&D”
[15], p. 1. The Call for Papers covers a range of topics
relevant to the aims of the Global Observatory. These
include ones on which HARPS has published articles in
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search results, as seen in the Australian article described
above [5]; papers measuring expenditure data with a
focus on R&D, as described in a recent Commentary by
Young et al. [16]; and landscape analyses of platforms
for implementing R&D, as described in the article by
Ongolo-Zogo et al. [17], analysing knowledge translation
platforms in Cameroon and Uganda, and partially in the
article by Yazdizadeh et al. [18], relaying lessons learnt
from knowledge networks in Iran.
Adam et al. also make clear that the topics listed in
the Call for Papers are examples and that the series edi-
tors are also willing to consider other areas [15]. Indeed,
in the Introduction to the Call for Papers, the import-
ance of capacity building is highlighted. This, too, is a
topic described in recent papers in HARPS, such as
those by Ager and Zarowsky [19], analysing the experi-
ences of the Health Research Capacity Strengthening
initiative’s Global Learning program of work across sub-
Saharan Africa, and by Hunter et al. [20], describing
needs assessment to strengthen capacity in water and
sanitation research in Africa.
Finally, as we noted in our earlier editorial [4], the
World Health Report 2013: Health Research for Univer-
sal Coverage showed how the demonstration of the ben-
efits from health research could be a strong motivation
for further funding of such research. As the Report
states, “adding impetus to do more research is a growing
body of evidence on the returns on investments … there is
mounting quantitative proof of the benefits of research to
health, society and the economy” [21]. We noted, too,
that since the Report’s publication in 2013, there had
been further examples from many countries of the bene-
fits from medical research. The REF2014 in the UK sig-
nifies an additional major boost to the evidence that a
wide range of health research does contribute to im-
proved health and other social benefits. The results of
such evaluations highlight the appropriateness of the
WHO’s actions in attempting to ensure all populations
share the benefits of health research endeavours by cre-
ating the Global Observatory on Health Research and
Development. This will not be an easy task, but we wel-
come the opportunity afforded by the current Call for
Papers for researchers and other stakeholders to engage
with this process and influence it [15].
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